Wells Fargo & Company Precipio, Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.33 - $0.7 $3 - $7	11 Added 0.1%	11,169 $4,000
Q1 2023 May 12, 2023	BUY	$0.6 - $1.0 $1 - $3	3 Added 0.03%	11,158 $7,000
Q4 2022 Feb 13, 2023	BUY	$0.5 - $17.4 $2 - $69	4 Added 0.04%	11,155 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.78 - $17.8 $0 - $17	-1 Reduced 0.01%	11,151 $9,000
Q2 2022 Aug 12, 2022	BUY	$0.98 - $1.68 $11 - $20	12 Added 0.11%	11,152 $12,000
Q1 2022 May 16, 2022	BUY	$1.19 - $1.71 $1 - $1	1 Added 0.01%	11,140 $15,000
Q3 2021 Nov 15, 2021	SELL	$2.78 - $3.63 $19 - $25	-7 Reduced 0.06%	11,139 $31,000
Q2 2021 Aug 16, 2021	BUY	$1.8 - $5.25 $61 - $178	34 Added 0.31%	11,146 $41,000
Q1 2021 May 13, 2021	BUY	$2.1 - $3.89 $23,100 - $42,790	11,000 Added 9821.43%	11,112 $25,000
Q4 2020 Feb 09, 2021	BUY	$1.94 - $2.64 $21 - $29	11 Added 10.89%	112 $0
Q3 2020 Nov 05, 2020	BUY	$1.16 - $7.0 $69 - $420	60 Added 146.34%	101 $0
Q1 2020 May 14, 2020	BUY	$0.68 - $2.3 $27 - $94	41 New	41 $0

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.